CCAP

Financial Services

Crescent Capital BDC, Inc. · Asset Management · $420M

UQS Score — Balanced Preset
57.2
Good

Crescent Capital BDC, Inc. scores 57.2/100 using the Balanced preset.

UQS vs Financial Services Sector
CCAP
57.2
Sector avg
39.7
Quality
Good
Moat
Weak
Growth
Neutral
Risk
Neutral
Valuation
Attractive

What is Crescent Capital BDC, Inc.?

Crescent Capital BDC, Inc. is a business development company focused on providing direct lending solutions to middle-market companies across the United States. Managed by an experienced credit-focused team, it operates within a well-established segment of private credit.

CCAP generates income by deploying capital directly into middle-market businesses — typically companies too large for traditional bank loans but outside the reach of public debt markets. The fund earns returns primarily through interest on loans and other credit instruments. Its investment mandate centers on privately negotiated debt transactions, giving investors exposure to a segment of the credit market not easily accessed through public markets.

Crescent Capital BDC was established in 2020 and is headquartered in Los Angeles, California.

  • Direct lending to U.S. middle-market companies
  • Private credit and loan fund strategies
  • Buyout and private equity-related financing
  • Customized debt solutions for sponsor-backed businesses

Is CCAP a Good Stock to Buy?

UQS Score rates CCAP as Good overall, reflecting a balanced profile across its five evaluation pillars.

The Quality pillar comes in at a Good rating, suggesting the underlying portfolio generates reasonably dependable income relative to BDC peers. Valuation is rated Attractive, meaning the market price appears to offer a reasonable entry point compared to fundamentals — a notable positive for income-oriented investors evaluating this sector.

The Moat pillar registers as Weak, which is common among BDCs that compete in a crowded direct-lending landscape without a clear structural advantage. Growth and Risk both sit at Neutral, indicating neither a strong tailwind nor an alarming headwind at this time.

See the exact pillar breakdown and full financial metrics by signing up for a UQS Pro account. Sign up free →

Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.

Does CCAP pay dividends?

Yes — Crescent Capital BDC, Inc. pays a dividend.

CCAP pays a regular dividend, consistent with the BDC structure that requires distributing the majority of taxable income to shareholders. This makes it a candidate for income-focused portfolios. The cadence and yield level relative to peers are available in the full UQS analysis — dividend sustainability is best evaluated alongside the Quality and Risk pillar scores.

When does CCAP report earnings?

Crescent Capital BDC reports earnings on a quarterly cadence, typical for U.S.-listed business development companies.

BDC earnings are driven primarily by net investment income and changes in portfolio fair value. CCAP's income generation relative to its cost of capital is a key metric tracked within the Quality pillar. Quarterly results can be volatile depending on credit market conditions and portfolio company performance.

For the most recent quarter's results and management commentary, visit Crescent Capital BDC's investor relations page directly.

CCAP Price History

+28.2% over 5Y

Monthly close, adjusted for stock splits and dividend reinvestment.

Return Calculator

What if I invested in Crescent Capital BDC, Inc.?

$
Today it would be worth
$12,688
That's a +26.9% total return, or +4.9% annualized.

Based on Crescent Capital BDC, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.

CCAP Long-term Outlook

With Growth rated Neutral and Risk also Neutral, CCAP's near-term trajectory appears stable rather than expansionary. The direct-lending market remains competitive, but middle-market credit demand provides a steady pipeline. The Attractive Valuation rating suggests the current price may already reflect near-term uncertainty, offering a potential margin of safety for patient investors.

Growth drivers

  • Sustained middle-market borrower demand for private credit solutions
  • Potential for net investment income growth as the portfolio scales
  • Favorable rate environment benefiting floating-rate loan portfolios

Key risks

  • Credit deterioration among middle-market borrowers in a downturn
  • Competitive pressure compressing loan spreads across the BDC sector
  • Regulatory or leverage constraints limiting portfolio expansion

CCAP vs Peers

CCAP operates in the closed-end fund and BDC space alongside a range of income-focused vehicles, each with distinct mandates.

BK-PA.TOCCAP scores lower
Canadian Banc Corp

Canadian Banc Corp focuses on Canadian bank preferred shares, offering a geographically distinct income strategy compared to CCAP's U.S. middle-market lending focus.

IFNCCAP scores higher
Aberdeen India Fund, Inc.

Aberdeen India Fund provides equity exposure to Indian markets, representing a growth-oriented emerging-market alternative to CCAP's credit-income model.

HQLCCAP scores higher
Tekla Life Sciences Investors

Tekla Life Sciences concentrates on healthcare and biotech equities, appealing to investors seeking sector-specific growth rather than private credit income.

Frequently Asked Questions

What does Crescent Capital BDC do?

Crescent Capital BDC is a business development company that lends directly to middle-market businesses in the United States. It focuses on privately negotiated debt transactions, earning income through interest and fees on loans made to companies that typically cannot access public debt markets easily.

Does CCAP pay dividends?

Yes, CCAP pays a regular dividend. As a BDC, it is required by regulation to distribute the majority of its taxable income to shareholders, making dividend payments a core feature of the investment. Income-focused investors often evaluate BDCs specifically for this characteristic.

When does CCAP report earnings?

Crescent Capital BDC reports on a quarterly cadence, in line with standard U.S. public company requirements. For exact dates and the most recent results, check the investor relations section of the company's official website.

Is CCAP a good stock to buy?

UQS Score rates CCAP as Good overall. The Valuation pillar is rated Attractive and Quality is Good, which may appeal to income investors. However, the Moat pillar is Weak, reflecting competitive pressures in direct lending. The complete pillar breakdown is available to UQS Pro members.

Is CCAP overvalued?

Based on the UQS Valuation pillar, CCAP is rated Attractive — meaning the current market price appears reasonable relative to the company's fundamentals. This does not guarantee future returns, but it suggests the stock is not pricing in excessive optimism at this time.

How does CCAP compare to its competitors?

CCAP's closest listed peers include Canadian Banc Corp, Aberdeen India Fund, and Tekla Life Sciences — each with very different mandates. CCAP is distinctive in its pure focus on U.S. middle-market private credit. Side-by-side UQS pillar comparisons are available on each ticker's page.

What is CCAP's market cap bracket?

CCAP is classified as a small-cap company. This places it in a segment of the market that can offer income opportunities but may also carry lower liquidity and higher sensitivity to credit market conditions than larger BDC peers.

Who founded Crescent Capital BDC?

Crescent Capital BDC was established in 2020 and is externally managed by Crescent Capital Group, a credit-focused alternative investment firm. Founding details about the broader Crescent Capital Group organization are publicly available through the company's official disclosures.

Is CCAP a long-term quality investment?

From a long-term quality standpoint, CCAP's Good UQS Score reflects a reasonably sound foundation, with an Attractive Valuation and Good Quality rating. The Weak Moat is worth monitoring over time, as durable competitive advantages matter for sustained long-term performance in any sector.

What is the main competitive advantage of Crescent Capital BDC?

CCAP benefits from its affiliation with Crescent Capital Group's established credit platform and deal-sourcing relationships in the middle market. However, the UQS Moat pillar rates this advantage as Weak, reflecting that structural differentiation in the BDC space remains difficult to sustain.

What sector does CCAP belong to?

CCAP operates within the Financial Services sector, specifically as a business development company in the private credit and direct-lending segment. BDCs are a regulated investment structure that sits at the intersection of private equity and fixed-income investing.

Is CCAP a growth stock or value stock?

CCAP leans toward the income and value side of the spectrum. The UQS Growth pillar is rated Neutral, indicating modest expansion expectations, while the Valuation pillar is Attractive — characteristics more consistent with an income-oriented value investment than a high-growth opportunity.

Unlock Full CCAP Analysis

Sign in to unlock the detailed analysis behind the UQS Score.

  • View the complete five-pillar UQS Score breakdown
  • Access detailed financial metrics and trend data
  • Compare CCAP against BDC sector peers
  • Track dividend sustainability indicators over time
  • Get the full risk and valuation deep-dive
  • Pro members see everything behind the score
Analyze CCAP in Detail →

Pro Analysis

CCAP — Score History

50556065Apr 2Apr 12Apr 22May 2May 12May 22May 24v5
Score changes· 3 most recent
DateUQSQualityMoatGrowthRiskValueChange
May 17, 202657.276.925.044.352.5100.0-0.1
May 16, 202657.376.925.044.852.5100.00.0
Apr 2, 202657.376.925.045.052.5100.0

CCAP — Pillar Breakdown

Quality

76.9/100 (25%)

Crescent Capital BDC, Inc. demonstrates outstanding capital efficiency and profitability, placing it among the highest-quality businesses in the market.

Return on EquityWeak

Profitability relative to shareholders' equity.

Operating ProfitabilityStrong

Ability to convert revenue into operating profit.

Net ProfitabilityStrong

Bottom-line profit as a share of revenue.

Cash GenerationStrong

Free cash flow relative to market value.

Growth

44.3/100 (20%)

Crescent Capital BDC, Inc. shows steady but unspectacular growth, typical for mature companies.

Recent Revenue TrendWeak

Revenue trajectory over the last twelve months.

3Y Revenue CAGRStrong

Compound annual revenue growth rate over 3 years.

EPS GrowthWeak

Year-over-year earnings per share growth.

Forward Revenue OutlookWeak

Analyst consensus for future revenue growth.

Forward EPS GrowthStrong

Analyst consensus for future earnings growth.

Risk

52.5/100 (15%)

Crescent Capital BDC, Inc. has some risk factors including moderate leverage or solvency concerns.

Debt/EquityModerate

Total debt relative to shareholder equity.

Current RatioStrong

Short-term liquidity — ability to pay near-term obligations.

Interest CoverageWeak

Earnings capacity relative to interest payments.

Valuation

100.0/100 (15%)

Crescent Capital BDC, Inc. appears attractively valued relative to its earnings, cash flows, and sector peers.

Earnings YieldStrong

Inverse of forward P/E — higher yield means cheaper stock.

Price to Free Cash FlowStrong

How many years of FCF the market cap represents.

PEG RatioStrong

P/E relative to earnings growth — lower is more attractive.

Moat

25/100 (25%)

Crescent Capital BDC, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for CCAP.

Score Composition

Quality
76.9×25%19.2
Growth
44.3×20%8.9
Risk
52.5×15%7.9
Valuation
100.0×15%15.0
Moat
25.0×25%6.3
Total
57.2Good

Financial Data

More Stock Analysis

How is the CCAP UQS Score Calculated?

The UQS (Unified Quality Score) for Crescent Capital BDC, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.

Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.

Moat (25%) assesses Crescent Capital BDC, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.

Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.

Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.

Valuation (15%) measures whether Crescent Capital BDC, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.

Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.